Suppr超能文献

变时性功能不全限制服用β受体阻滞剂患者的有氧运动能力:对连续患者的真实观察

Chronotropic Incompetence Limits Aerobic Exercise Capacity in Patients Taking Beta-Blockers: Real-Life Observation of Consecutive Patients.

作者信息

Smarz Krzysztof, Tysarowski Maciej, Zaborska Beata, Pilichowska-Paszkiet Ewa, Sikora-Frac Małgorzata, Budaj Andrzej, Jaxa-Chamiec Tomasz

机构信息

Department of Cardiology, Centre of Postgraduate Medical Education, Grochowski Hospital, 04-073 Warsaw, Poland.

Department of Medicine, Rutgers University New Jersey Medical School, Newark, NJ 07103, USA.

出版信息

Healthcare (Basel). 2021 Feb 16;9(2):212. doi: 10.3390/healthcare9020212.

Abstract

BACKGROUND

Chronotropic incompetence in patients taking beta-blockers is associated with poor prognosis; however, its impact on exercise capacity (EC) remains unclear.

METHODS

We analyzed data from consecutive patients taking beta-blockers referred for cardiopulmonary exercise testing to assess EC. Chronotropic incompetence was defined as chronotropic index (CI) ≤ 62%.

RESULTS

Among 140 patients all taking beta-blockers (age 61 ± 9.7 years; 73% males), 64% with heart failure, chronotropic incompetence was present in 80.7%. EC assessed as peak oxygen uptake was lower in the group with chronotropic incompetence, 18.3 ± 5.7 vs. 24.0 ± 5.3 mL/kg/min, < 0.001. EC correlated positively with CI (β = 0.14, < 0.001) and male gender (β = 5.12, < 0.001), and negatively with age (β = -0.17, < 0.001) and presence of heart failure (β = -3.35, < 0.001). Beta-blocker dose was not associated with EC. Partial correlation attributable to CI accounted for more than one-third of the variance in EC explained by the model (adjusted R = 59.8%).

CONCLUSIONS

In patients taking beta-blockers, presence of chronotropic incompetence was associated with lower EC, regardless of the beta-blocker dose. CI accounted for more than one-third of EC variance explained by our model.

摘要

背景

服用β受体阻滞剂的患者心率变时性功能不全与预后不良相关;然而,其对运动能力(EC)的影响仍不清楚。

方法

我们分析了连续服用β受体阻滞剂并接受心肺运动试验以评估EC的患者的数据。心率变时性功能不全定义为变时指数(CI)≤62%。

结果

在140例均服用β受体阻滞剂的患者中(年龄61±9.7岁;73%为男性),64%患有心力衰竭,80.7%存在心率变时性功能不全。心率变时性功能不全组以峰值摄氧量评估的EC较低,分别为18.3±5.7与24.0±5.3 mL/kg/min,P<0.001。EC与CI呈正相关(β=0.14,P<0.001)以及与男性性别呈正相关(β=5.12,P<0.001),而与年龄呈负相关(β=-0.17,P<0.001)以及与心力衰竭的存在呈负相关(β=-3.35,P<0.001)。β受体阻滞剂剂量与EC无关。由CI引起的偏相关占模型解释的EC方差的三分之一以上(调整R=59.8%)。

结论

在服用β受体阻滞剂的患者中,无论β受体阻滞剂剂量如何,心率变时性功能不全的存在均与较低的EC相关。CI占我们模型解释的EC方差的三分之一以上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60f/7920432/167115d7fbba/healthcare-09-00212-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验